News from Decision Resources Group A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Oct 10, 2017, 11:52 ET Pharma's approach to market access facing digital disruption, study finds

The pharmaceutical industry's traditional approach to market access is failing to meet the information needs of formulary decision makers heavily...


Oct 06, 2017, 08:30 ET DRG Expects the Pancreatic Cancer Market to Grow at an annual rate of 10% over the next 10 years to Reach Almost $4 Billion in 2026

Decision Resources Group finds that the pancreatic cancer market will grow from $1.3 billion in 2016 to $3.7 billion in 2026. This growth will be...


Sep 07, 2017, 16:06 ET The Launch of First-in-Class Biologic Therapies Will Drive Significant Growth Within the Osteoarthritic Pain Market Through 2026

Decision Resources Group finds that the launch of novel biologic therapies targeting nerve growth factor (NGF) will be the main driver of growth in...


Aug 22, 2017, 08:22 ET The Gastroesophageal Cancer Market is Expected to Grow Sevenfold Over the Next Ten Years Capturing $13 Billion in 2026

Decision Resources Group finds that the gastroesophageal cancer market will grow significantly from almost $2 billion in 2016 to $13 billion in...


Aug 16, 2017, 10:22 ET DRG's Formulary Insights Sheds Light on Dangers, Opportunities Related to Formulary Trends

Decision Resources Group (DRG), leading provider of healthcare market intelligence, has launched a research initiative that dives into the dynamics...


Aug 16, 2017, 09:00 ET Decision Resources Group Acquires Context Matters to Expand Global Market Access Intelligence Offerings

Decision Resources Group (DRG), the life sciences industry's most trusted provider of market intelligence and global data products and services,...


Aug 14, 2017, 14:23 ET Decision Resources Group Rates Advancement of Influential IDNs

Leading provider of healthcare research and analytics, Decision Resources Group (DRG), has introduced a new methodology for analyzing and...


Aug 14, 2017, 13:41 ET DRG Gauges Impact of Managed Care Dynamics on Medical Device Industry at a Local Level

Decision Resources Group, premier provider of healthcare market intelligence, recently announced the addition of a new module to its Market...


Aug 08, 2017, 12:10 ET Survey of Payers and Gastroenterologists Finds Excitement Over the Prospect of JAK Inhibitors to Treat Inflammatory Bowel Disease

Decision Resources Group finds that surveyed health insurance medical and pharmacy directors as well as gastroenterologists look favorably on Janus...


Aug 01, 2017, 13:09 ET Emerging Immune Checkpoint Inhibitors May Find the Road to Optimal Market Access Rocky

Decision Resources Group finds that, despite mixed fortunes in health technology assessment (HTA) across the EU5 (France, Germany, Italy, Spain,...


Aug 01, 2017, 12:30 ET Doctors say pharma rep details are stale, need updating for digital age

Despite the pharma sales force making great strides towards "digitizing the field" with tablets and other technologies – a new study from DRG...


Jul 19, 2017, 09:22 ET Eylea Will Dominate The Wet Age-Related Macular Degeneration Market Until 2018, When Its Share Will Become Threatened By Emerging Products

Decision Resources Group finds that over the next ten years, the market for late age-related macular degeneration (AMD) therapies will become...


Jun 28, 2017, 10:42 ET With Launch of Generic Inhaled Therapies for Asthma and COPD, Devices will Allow Some Drugs to Stand Out

Decision Resources Group finds that practitioners prescribing inhaled therapies prefer simpler devices. Although the diverse array of drug/device...


Jun 27, 2017, 09:12 ET Survey Shows Intensifying Focus on Cost and Demonstration of Value in Increasingly Competitive Orphan Drug Space

Decision Resources Group finds that more than 40% of surveyed U.S. physicians perceive an increase over the last three years in the degree of payer...


Jun 26, 2017, 08:45 ET Acute Heart Failure Treatment Dominated by Therapies Effective at Relieving Symptoms

Decision Resources Group finds that, in the absence of therapies able to improve long-term outcomes, treatment approaches in Acute Heart Failure...


Jun 02, 2017, 14:55 ET Decision Resources Group Appoints Lou Pascarella as Executive Vice President, Global Sales

Decision Resources Group (DRG), a subsidiary of India-based Piramal Enterprises Limited (Piramal), today announced that Lou Pascarella has joined...


Jun 01, 2017, 10:52 ET Costly Atopic Dermatitis Therapies Impact Traditionally Low-Cost Market

Decision Resources Group finds that efficacy in atopic dermatitis patients refractory to topicals and conventional systemics will be a key driver...


May 30, 2017, 08:51 ET Disease-Modifying Therapies: An Unmet Need for Patients with Diabetic Nephropathy

Decision Resources Group finds that approximately 66% of surveyed physicians in the United States and 70% in Europe (United Kingdom, France, and...


May 16, 2017, 12:01 ET Decision Resources Group Consulting Ranks No. 14 on 2017 Top Consulting Firms by Ivy Exec

Ivy Exec has ranked Decision Resources Group Consulting (DRGC) on its 2017 Top Consulting Firms to Work For rankings for the second year in a row....


May 15, 2017, 10:17 ET Poor pharma digital marketing damages credibility with physicians, Manhattan Research study finds

Physicians value useful content from pharma that helps them do their jobs and manage care better, such as quality scientific information, patient...


May 04, 2017, 08:00 ET DRG unveils new innovation in network meta-analysis

A novel web-based interactive 3-dimensional (3-D) tool has been developed by Decision Resources Group Abacus in collaboration with leading...


Mar 16, 2017, 13:00 ET Unmet Need and Opportunity Assessment in Recurrent or Metastatic SCCHN: Are Immune Checkpoint Inhibitors the Answer?

Decision Resources Group finds in a survey of U.S. and European oncologists, that in contrast to many other oncology indications, incidence of...


Mar 16, 2017, 08:30 ET PCSK9 Inhibitors Improve Patient Outcomes, But Will That Convince Payers to Pay for Them?

Decision Resources Group finds that the PCSK9 inhibitor agents are expected to become blockbusters on the back of positive outcomes data, but the...


Mar 15, 2017, 13:30 ET Rising Drug-Resistance Rates Continue to Erode the Utility of Frontline Antibiotics, Driving Uptake of New Antibiotic Brands in the Hospital-Treated Gram-Negative Infections Market

Decision Resources Group finds that the hospital-treated Gram-negative infection (GNI) market continues to be dominated by well-entrenched,...


Mar 15, 2017, 10:05 ET Small but Valuable: How Unmet Need in the Severe Asthma Market is Driving Nucala Sales and Offers Opportunity for Others, Including, Teva, AstraZeneca, Sanofi, and Regeneron

Decision Resources Group finds that Nucala's novel mechanism of action and specific indication for eosinophilic asthma are key drivers behind the...